Answers are grounded in this paper and cite their sources.
Oral therapy options for pyelonephritis caused by ESBL producing E. coli are limited. We describe a woman with relapsing pyelonephritis due to a CTX-M ESBL E. coli who was cured with a prolonged course of pivmecillinam. This suggests pivmecillinam may be effective treatment for selected patients with pyelonephritis with these organisms.
No takes yet. Share an insight, caveat, or question.
Nicolle et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: